Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Monofer vs oral iron sulfate in chemotherapy-induced anemia
2009-016727-53Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Mar 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric derisomaltose in chemotherapy-induced anaemia (CIA), cancer and anaemia (2 arms), sponsored by Pharmacosmos. Primary endpoint: Change in hemoglobin from baseline to week 12. Started Mar 2010; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
chemotherapy-induced anaemia (CIA)canceranaemia
Beyond the preview
Go deeper on 2009-016727-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016727-53.